mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.15 |
0.2 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |